• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Most commonly used HIV drug worldwide not associated with increased risk for suicide in Uganda

byCaitlyn HuiandDeepti Shroff Karhade
June 28, 2018
in Chronic Disease, Infectious Disease, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. No baseline differences observed between patients exposed to efavirenz and nevirapine compared to those never exposed, regarding both depression and suicide.

2. No significant associations found between efavirenz and suicidal ideation in persons living with HIV in Uganda.

Evidence Rating Level: 2 (Good)

Study Rundown: The authors of this study examined the effects of an HIV treatment, efavirenz, which is a nonnoncleoside reverse transcriptase inhibitor used commonly in both low and high-income countries. The purpose of this study was to assess the associations between efavirenz use and depression and suicide ideation in persons living with HIV in Uganda. Generally, they observed there was not an increased risk for suicide in Uganda with efavirenz use. This study had several limitations. Of note, assignment between the treatment groups to efavirenz and nevirapine groups was nonrandom. Further, depression was measured through subjective reporting via a self-reported questionnaire.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Associated Factors of Suicidal Thoughts in HIV-Positive Individuals

RELATED REPORTS

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

Calorie restriction and low-fat diets may reduce depression in individuals with higher cardiometabolic risk

In-Depth [prospective cohort]: In this prospective cohort study, a total of 692 patients were included and observed every 3 to 4 months from 2005 to 2015. The measurements of interest included depression and suicidal ideation. Depression was measured through a 15-item depression subscale of the Hopkins Symptom Checklist that was previously validated in the study population. The incidence of first suicide ideation was 3.1 and 7.4 per 100 person-years for the efavirenz- and nevirapine-exposed groups. The difference was -4.2 (CI, -6.8 to -1.5) events per 100 person-years. Further, efavirenz use was not significantly associated with suicidal ideation (adjusted odds ratio, 0.61 (CI, 0.30 to 1.25); P = 0.178) with the GEE model. Similarly, efavirenz was not significantly associated with suicidal ideation based on the Cox proportional hazards regression model.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depressionhuman immunodeficiency virus (HIV)suicide
Previous Post

Nonsurgical treatment of small tumor renal cancer may be as effective as radical nephrectomy but with fewer complications

Next Post

Fruquintinib increases overall survival in metastatic colorectal carcinoma

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients

June 20, 2025
Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

June 16, 2025
Vegetarian diet may lower incidence of colorectal cancer
Psychiatry

Calorie restriction and low-fat diets may reduce depression in individuals with higher cardiometabolic risk

May 20, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
Next Post

Fruquintinib increases overall survival in metastatic colorectal carcinoma

American Academy of Pediatrics recommends standards for adverse event disclosures

Ambulatory surgery center and office-based setting results in similar outcomes for abortion

FDA-approved weight loss medications associated with weight loss at one year

Reduced incidence of major cardiovascular events for at-risk patients adherent to Mediterranean diet

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.